Investing Profile
Sakae Asanuma
Your Intro Paths to Sakae Asanuma
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Sakae is a member of
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Carnegie Mellon University - Tepper School of Business Network
33 CONNECTIONS
Find Sakae Asanuma on
cbCurrent Investing Position
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
15
Sakae Asanuma is on these Sector & Stage Rankings
Sakae Asanuma's Investments On Record (9)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Storm Therapeutics | Series CApr 2026$56M Series AMay 2019$18M Series AJan 2018$5M | $130M |
Crossbow Therapeutics | Series BMar 2026$77M | $160M |
Cellvie | SeedSep 2025$5M SeedFeb 2023$6M | $11M |
Normunity | Series BJan 2025$75M | $140M |
Anavo Therapeutics | SeedMay 2023$9M SeedApr 2021$24M | $33M |
Dren Bio | Series BJun 2022$65M Series AOct 2020$60M | $130M |
Vertero | Series COct 2021$37M Series BJun 2019$10M | $110M |
Orna Therapeutics | Series AFeb 2021$80M | $320M |
Sakae Asanuma's Experience
Buyside Analyst HotmailPresent
Director HotmailPresent
President and CEO Astellas Pharma USPresent
President & CEO HotmailPresent
Sakae Asanuma's Education
Carnegie Mellon University - Tepper School of Business MBA Finance, Accounting, Entrepreneurship
Investors who invest with Sakae Asanuma
Scouts & Angels Affiliated With Sakae Asanuma